ART era has changed secondary cancers after Kaposi sarcoma

August 25, 2017

(HealthDay)—There has been a significant decline in the risk of secondary cancers after Kaposi sarcoma (KS) in the era of highly-active antiretroviral therapy (HAART), according to a study published online Aug. 24 in JAMA Oncology.

Fahad Mukhtar, M.D., M.P.H., from the University of South Florida in Tampa, and colleagues calculated the standardized incidence ratios (SIRs) for the development of new secondary cancer in the pre-AIDS era (1973 to 1979), pre-HAART era (1980 to 1995), and the HAART era (1996 to 2013). Data were included for 14,905 individuals with diagnosed KS.

The researchers found that the SIRs were 2.01, 49.70, 4.98, 13.70, 6.40, and 48.97 for cancers of the rectum, anus, liver, cervix, Hodgkin's , and non-Hodgkin's lymphoma, respectively, from 1980 to 1995. The associations with KS persisted for cancer of the anus, Hodgkin's lymphoma, non-Hodgkin's lymphoma, and cancer of the liver from 1996 to 2013; in addition, significant SIRs were seen for cancer of the tongue, cancer of the penis, and (SIRs, 6.99, 10.28, and 17.62, respectively). From the pre-HAART era to the HAART era there was a significant decrease in the SIR of developing any tumor after KS, from 3.36 to 1.94.

"Certain cancers, including acute lymphocytic leukemia, cancer of the tongue, and of the penis, are increasingly becoming more common in the HAART era compared with the pre-HAART era," the authors write.

Explore further: Cancer burden shifts for people with HIV/AIDS

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Cancer burden shifts for people with HIV/AIDS

April 11, 2011
The number of cancers and the types of cancers among people living with AIDS in the U.S. have changed dramatically during the 15-year period from 1991-2005, according to an article published online April 11th in the Journal ...

Risk of HPV-linked second cancers up after anal cancer

June 15, 2017
(HealthDay)—Survivors of squamous cell carcinoma of the anus (SCCA) have an elevated risk of human papillomavirus (HPV)-related second primary malignancies (SPMs), according to a study published online June 13 in Cancer.

Cancer burden may be changing for people living with HIV

April 5, 2017
The total number of cancer cases diagnosed among people living with the human immunodeficiency virus (HIV) is projected to decline in coming years, due mostly to declines in non-Hodgkin lymphoma and Kaposi sarcoma. Certain ...

Second cancer risk persists for Hodgkin's lymphoma survivors

December 29, 2015
(HealthDay)—Hodgkin's lymphoma survivors have an increased risk of a second cancer, with risk still elevated at 35 years or more after treatment, according to a study published in the Dec. 24 issue of the New England Journal ...

Increased cancer risk for childhood kidney recipients

April 5, 2017
(HealthDay)—Childhood kidney recipients have increased cancer risk, according to a study published online March 29 in the American Journal of Transplantation.

HIV status doesn't influence Hodgkin's lymphoma outcome

October 11, 2012
(HealthDay)—Despite more extensive disease and more adverse prognostic factors, HIV-positive patients with Hodgkin's lymphoma (HL) do not have worse outcomes when treated with doxorubicin, bleomycin, vinblastine, and dacarbazine ...

Recommended for you

Lung cancer drug could be repurposed to target 'zombie' proteins linked to leukemia

September 25, 2018
A new study by scientists at the University of Liverpool highlights how a clinically-approved lung cancer drug could potentially be 'repurposed' to design new treatments for future cancer therapies.

A protein called vaccinia-related kinase 1 may help cancer establish itself in new areas of the body during metastasis

September 25, 2018
Sometimes negative results can point researchers in the right direction.

Combo therapy of prostatectomy plus radiotherapy may improve survival in prostate cancer

September 25, 2018
High-risk prostate cancer, that which has continued to grow but not yet metastasized, is commonly treated with combination therapies. Each method has pros and cons, but there is little clarity whether one might be more effective ...

Brigatinib becomes potential new first-line option for ALK-positive non-small lung cancer

September 25, 2018
Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for ...

Two studies describe improved approach to bone marrow transplant

September 25, 2018
Two recent studies in the journal Leukemia present a new approach for bone marrow donation and transplant that preclinical laboratory tests suggest could make the life-saving procedure safer and more effective for patients.

Unhealthy lifestyle responsible for 45,000 predicted cases of bowel cancer in next decade

September 25, 2018
A UNSW study shows that a large proportion of bowel cancers in Australia are preventable by adopting a healthy lifestyle – particularly for men.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.